Skip to Main Content

Paper Details

Interleukin-17 limits hypoxia-inducible factor 1α and development of hypoxic granulomas during tuberculosis.
JCI insight
29
2017
HIF1, HIF1 mRNA, IL-17, IL-17 promoter, IL-17A, Interleukin-17, Mtb, Mycobacterium tuberculosis, TB, TB granulomas, drug, human, hypoxia-inducible factor 1, hypoxic granulomas, hypoxic necrotic granulomas, mouse, patients, phenolic, pulmonary tuberculosis, rs2275913, single nucleotide polymorphism, transcription factor, tuberculosis
Author NameAffiliation
Reid TownsendWashington University in St. Louis
William HorneRichard King Mellon Institute for Pediatric Research, University of Pittsburgh School of Medicine
Maxim N ArtyomovWashington University School of Medicine
  • 1 - 3

Datasets

Release 1.2